519 related articles for article (PubMed ID: 34207035)
1. Tumor-Associated Macrophages as Multifaceted Regulators of Breast Tumor Growth.
Munir MT; Kay MK; Kang MH; Rahman MM; Al-Harrasi A; Choudhury M; Moustaid-Moussa N; Hussain F; Rahman SM
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207035
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Polarization States in the Tumor Microenvironment.
Boutilier AJ; Elsawa SF
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
[TBL] [Abstract][Full Text] [Related]
4. Mouse 4T1 Breast Cancer Cell-Derived Exosomes Induce Proinflammatory Cytokine Production in Macrophages via miR-183.
Guo J; Duan Z; Zhang C; Wang W; He H; Liu Y; Wu P; Wang S; Song M; Chen H; Chen C; Si Q; Xiang R; Luo Y
J Immunol; 2020 Nov; 205(10):2916-2925. PubMed ID: 32989094
[TBL] [Abstract][Full Text] [Related]
5. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
6. GATA3 as a master regulator for interactions of tumor-associated macrophages with high-grade serous ovarian carcinoma.
El-Arabey AA; Denizli M; Kanlikilicer P; Bayraktar R; Ivan C; Rashed M; Kabil N; Ozpolat B; Calin GA; Salama SA; Abd-Allah AR; Sood AK; Lopez-Berestein G
Cell Signal; 2020 Apr; 68():109539. PubMed ID: 31935430
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: As Critical Regulators of Tumor- Associated Macrophages.
Chatterjee B; Saha P; Bose S; Shukla D; Chatterjee N; Kumar S; Tripathi PP; Srivastava AK
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992449
[TBL] [Abstract][Full Text] [Related]
8. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives.
Mehraj U; Qayoom H; Mir MA
Breast Cancer; 2021 May; 28(3):539-555. PubMed ID: 33661479
[TBL] [Abstract][Full Text] [Related]
10. Slit2 Inhibits Breast Cancer Metastasis by Activating M1-Like Phagocytic and Antifibrotic Macrophages.
Ahirwar DK; Charan M; Mishra S; Verma AK; Shilo K; Ramaswamy B; Ganju RK
Cancer Res; 2021 Oct; 81(20):5255-5267. PubMed ID: 34400395
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated tumor-associated macrophages in carcinogenesis, progression and targeted therapy of gynecological and breast cancers.
Xu T; Yu S; Zhang J; Wu S
J Hematol Oncol; 2021 Oct; 14(1):181. PubMed ID: 34717710
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line.
Moradi-Chaleshtori M; Bandehpour M; Heidari N; Mohammadi-Yeganeh S; Mahmoud Hashemi S
Int Immunopharmacol; 2021 Jan; 90():107198. PubMed ID: 33249048
[TBL] [Abstract][Full Text] [Related]
13. Cancer-derived exosomal miR-138-5p modulates polarization of tumor-associated macrophages through inhibition of KDM6B.
Xun J; Du L; Gao R; Shen L; Wang D; Kang L; Chen C; Zhang Z; Zhang Y; Yue S; Feng S; Xiang R; Mi X; Tan X
Theranostics; 2021; 11(14):6847-6859. PubMed ID: 34093857
[No Abstract] [Full Text] [Related]
14. Pathologic assessment of tumor-associated macrophages and their histologic localization in invasive breast carcinoma.
Mwafy SE; El-Guindy DM
J Egypt Natl Canc Inst; 2020 Jan; 32(1):6. PubMed ID: 32372332
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages: role in cancer development and therapeutic implications.
Salmaninejad A; Valilou SF; Soltani A; Ahmadi S; Abarghan YJ; Rosengren RJ; Sahebkar A
Cell Oncol (Dordr); 2019 Oct; 42(5):591-608. PubMed ID: 31144271
[TBL] [Abstract][Full Text] [Related]
16. Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer.
Du S; Qian J; Tan S; Li W; Liu P; Zhao J; Zeng Y; Xu L; Wang Z; Cai J
Cancer Lett; 2022 Mar; 529():168-179. PubMed ID: 35007697
[TBL] [Abstract][Full Text] [Related]
17. The Impact of the Tumor Microenvironment on Macrophage Polarization in Cancer Metastatic Progression.
Wang H; Yung MMH; Ngan HYS; Chan KKL; Chan DW
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207286
[TBL] [Abstract][Full Text] [Related]
18. STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment.
Jesser EA; Brady NJ; Huggins DN; Witschen PM; O'Connor CH; Schwertfeger KL
Breast Cancer Res; 2021 Nov; 23(1):104. PubMed ID: 34743736
[TBL] [Abstract][Full Text] [Related]
19. Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer.
Tariq M; Zhang J; Liang G; Ding L; He Q; Yang B
J Cell Biochem; 2017 Sep; 118(9):2484-2501. PubMed ID: 28106295
[TBL] [Abstract][Full Text] [Related]
20. Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review).
Su P; Li O; Ke K; Jiang Z; Wu J; Wang Y; Mou Y; Jin W
Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38695252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]